BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31467227)

  • 1. Association of Leukemia Target Genes
    Li J; Zhang W; Liu W; Rong J; Chen Y; Gu W; Zhang W
    Cancer Genomics Proteomics; 2019; 16(5):333-344. PubMed ID: 31467227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
    Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
    Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TET2 mutations in childhood leukemia.
    Langemeijer SM; Jansen JH; Hooijer J; van Hoogen P; Stevens-Linders E; Massop M; Waanders E; van Reijmersdal SV; Stevens-Kroef MJ; Zwaan CM; van den Heuvel-Eibrink MM; Sonneveld E; Hoogerbrugge PM; van Kessel AG; Kuiper RP
    Leukemia; 2011 Jan; 25(1):189-92. PubMed ID: 21042320
    [No Abstract]   [Full Text] [Related]  

  • 4. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration.
    Liu J; Hong J; Han H; Park J; Kim D; Park H; Ko M; Koh Y; Shin DY; Yoon SS
    Br J Cancer; 2020 May; 122(10):1445-1452. PubMed ID: 32203209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.
    Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS
    Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
    Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
    Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis.
    Liu WJ; Tan XH; Luo XP; Guo BP; Wei ZJ; Ke Q; He S; Cen H
    Leuk Lymphoma; 2014 Dec; 55(12):2691-8. PubMed ID: 24524305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment.
    Lee C; Lee S; Park E; Hong J; Shin DY; Byun JM; Yun H; Koh Y; Yoon SS
    Genome Med; 2022 Sep; 14(1):111. PubMed ID: 36171613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 gene and its family genes Bax, Bcl-Xl as well as Fas/Apo-1 and their clinical significance in acute leukemia.
    Chen Y; Zhou J; Yue B; Xiang Z; Song X; Li C; Wang B
    Chin Med J (Engl); 1998 Aug; 111(8):682-5. PubMed ID: 11245018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1.
    Das AB; Kakadia PM; Wojcik D; Pemberton L; Browett PJ; Bohlander SK; Vissers MCM
    Blood Cancer J; 2019 Oct; 9(10):82. PubMed ID: 31578317
    [No Abstract]   [Full Text] [Related]  

  • 13. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
    Kozopas KM; Yang T; Buchan HL; Zhou P; Craig RW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3516-20. PubMed ID: 7682708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.
    Seipel K; Graber C; Flückiger L; Bacher U; Pabst T
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
    Wang R; Gao X; Yu L
    BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.
    Li MJ; Yang YL; Lee NC; Jou ST; Lu MY; Chang HH; Lin KH; Peng CT; Lin DT
    J Formos Med Assoc; 2016 Sep; 115(9):801-6. PubMed ID: 26414667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.
    Casabonne D; Gracia E; Espinosa A; Bustamante M; Benavente Y; Robles C; Costas L; Alonso E; Gonzalez-Barca E; Tardón A; Dierssen-Sotos T; Vázquez EG; Aymerich M; Campo E; Jiménez-Moleón JJ; Marcos-Gragera R; Castaño-Vinyals G; Aragones N; Pollan M; Kogevinas M; Urtiaga C; Amiano P; Moreno V; de Sanjose S
    Eur J Nutr; 2017 Apr; 56(3):1123-1133. PubMed ID: 26838684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
    Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
    Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
    Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
    Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.